A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimo...

por Gómez-Aguayo, Francisco, Paczka, José A., Leñero-Córdova, Rubén, Jiménez-Román, Jesús, Davila-Villarreal, Jaime, Hartleben, Curt, Baiza-Durán, Leopoldo, Olvera-Montaño, Oscar, García-Velez, Francisco, Muñoz-Villegas, Patricia
Publicado 2018